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Summary
Modification of AMPA receptor function is a major
mechanism for the regulation of synaptic transmis-
sion and underlies several forms of synaptic plastic-
ity. Post-translational palmitoylation is a reversible
modification that regulates localization of many pro-
teins. Here, we report that palmitoylation of the AMPA
receptor regulates receptor trafficking. All AMPA re-
ceptor subunits are palmitoylated on two cysteine
residues in their transmembrane domain (TMD) 2 and
in their C-terminal region. Palmitoylation on TMD 2 is
upregulated by the palmitoyl acyl transferase GODZ
and leads to an accumulation of the receptor in the
Golgi and a reduction of receptor surface expression.
C-terminal palmitoylation decreases interaction of the
AMPA receptor with the 4.1N protein and regulates
AMPA- and NMDA-induced AMPA receptor internal-
ization. Moreover, depalmitoylation of the receptor is
regulated by activation of glutamate receptors. These
data suggest that regulated palmitoylation of AMPA
receptor subunits modulates receptor trafficking and
may be important for synaptic plasticity.
Introduction
Glutamate is the major excitatory neurotransmitter in
the mammalian central nervous system. The ionotropic
glutamate receptors (GluRs) are classified into several
groups, namely, AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazole propionate), KA (kainate), δ (delta), and NMDA
(N-methyl-D-aspartate) receptors. The AMPA receptor
is a ligand-gated cation channel that mediates the fast
component of excitatory postsynaptic currents in the
central nervous system. The AMPA receptor consists of
four types of subunits, GluR1, GluR2, GluR3, and GluR4
(Hollmann and Heinemann, 1994). Many studies have
shown that post-translational modifications, such as
phosphorylation of AMPA receptor subunits, play criti-
cal roles in the regulation of synaptic plasticity (Soder-
ling and Derkach, 2000; Song and Huganir, 2002;
Swope et al., 1999). Protein phosphorylation of AMPA
receptors modulates AMPA receptor ion channel prop-
erties as well as the membrane trafficking of AMPA re-
ceptors to the postsynaptic membrane (Song and Hu-
ganir, 2002).*Correspondence: rhuganir@jhmi.eduAnother type of protein modification that regulates
localization of proteins is post-translational fatty acyla-
tion, such as palmitoylation (Bijlmakers and Marsh,
2003; El-Husseini and Bredt, 2002; Resh, 1999). Pal-
mitic acid is a 16 carbon-containing saturated fatty acid
and is the most abundant fatty acid in the brain. Palmi-
tate forms a covalent attachment to proteins via thioes-
ter bonds at cytosolic cysteine residues that, like phos-
phorylation, is labile and reversible. Some neuronal
receptors and ion channels are known to be palmitoy-
lated, such as the α subunit of Na+ channels (Schmidt
and Catterall, 1987), β2a subunit of Ca2+ channels (Chien
et al., 1996; Qin et al., 1998), serotonin (5-hydroxytrypt-
amine, 5-HT), 1B and 4A receptors (Ng et al., 1993;
Ponimaskin et al., 2002, 2001), dopamine D1 and D2L
receptors (Ng et al., 1994a, 1994b), α7 subunit of nico-
tinic receptors (Drisdel et al., 2004), and γ2 subunit of
GABAA receptors (Keller et al., 2004). Among glutamate
receptors, palmitoylation of the GluR6 KA receptor has
been reported at its C-terminal cysteine residues,
Cys827 and Cys840 (Pickering et al., 1995). In addition,
metabotropic mGluR4, but not mGluR1α, is palmitoy-
lated (Alaluf et al., 1995). Moreover, several GluR recep-
tor-interacting proteins, PSD-95, PSD-93, GRIP1b, and
GRIP2b/pABP-L, are palmitoylated at their N-terminal
regions, whereas SAP-97, SAP102, GRIP1a, and GRIP2a/
ABP-L are not palmitoylated (Craven et al., 1999; De-
Souza et al., 2002; El-Husseini et al., 2000b; Topinka
and Bredt, 1998; Yamazaki et al., 2001). Previous
studies have shown that palmitoylation of PSD-95 reg-
ulates AMPA receptor accumulation at synapses, and
glutamate-induced AMPA receptor internalization re-
quires depalmitoylation of PSD-95 (El-Husseini et al.,
2000a, 2002). Palmitate cycling on PSD-95 at the syn-
apse regulates surface expression of the AMPA recep-
tor, and palmitoylated GRIP1b and pABP-L are impor-
tant for membrane trafficking of the AMPA receptor
(Bredt and Nicoll, 2003). However, in contrast to AMPA
receptor-interacting proteins, palmitoylation of AMPA
receptor subunits has not been investigated. Here, we
show that all four types of AMPA receptor subunits
GluR1–GluR4 are palmitoylated at two sites on their
transmembrane domain (TMD) 2 and C-terminal do-
mains. TMD 2 palmitoylation is increased by the palmi-
toyl acyl transferase GODZ and causes accumulation
of the receptor in the Golgi apparatus. Palmitoylation
on the C-terminal domain inhibits its interaction with
the 4.1N protein, which has previously been shown to
stabilize AMPA receptor expression on the cell surface
(Shen et al., 2000). Mutation of these C-terminal palmi-
toylation sites increases GluR1 association with the
4.1N protein and inhibits the regulated endocytosis of
AMPA receptors. Finally, depalmitoylation of the AMPA
receptor in neurons is regulated by glutamate treat-
ment. These data suggest that palmitoylation may play
important roles in the postsynaptic trafficking of AMPA
receptors and in the regulation of excitatory synaptic
transmission.
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Palmitoylation of the AMPA Receptor Subunits
GluR1–GluR4 in Their C-Terminal Regions
Many proteins are post-translationally palmitoylated
and regulated in the cell. Protein palmitoylation is regu-
lated by the balance of palmitoyl acyl transferase (PAT)
and palmitoyl thioesterase (PTE) activities in vivo. To
test whether AMPA receptor subunits were palmitoy-
lated, we transfected AMPA receptor subunits GluR1 or
GluR2 into HEK 293T cells and metabolically labeled
these HEK 293T cells with [3H]palmitic acid. Metabolic
labeling showed that both GluR1 and GluR2 were pal-
mitoylated in HEK 293T cells (Figure 1A). The GluR6
kainate receptor subunit, which was previously re-
ported to be palmitoylated (Pickering et al., 1995), was
used as a positive control for [3H]palmitate labeling.
These results indicate that endogenous PATs appear to
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iFigure 1. Palmitoylation of the AMPA Receptor Subunits GluR1–4 on their C Termini
(A) Palmitoylation of GluR1, GluR2, or GluR6 in transfected HEK 293T cells. Expression and immunoprecipitation (IP) of each GluR protein
was confirmed by Western blotting (WB) (top). IP and [3H]-palmitate incorporation were shown (bottom).
(B) Hydroxylamine treatment of palmitoylated GluR1 and GluR2. Expression in transfected HEK 293T cells and IP of each GluR protein
confirmed by WB (top). IP and [3H]-palmitate incorporation of control, Tris-HCl-treated (middle), and hydroxylamine- (NH2OH)-treated (bottom)
samples were shown.
(C) C-terminal amino acid sequences of AMPA receptor subunits GluR1–4 following transmembrane domain (TMD) 4. An arrow indicates
conserved cysteine residues and arrowheads indicate additional cysteine residues.
(D) Identification of AMPA receptor palmitoylation sites. GluR1–4 wild-type (WT) and GluR1C811S, GluR2C836S, GluR3C841S, or GluR4C817S
were labeled with [3H]-palmitate in transfected HEK 293T cells. Western blotting (WB) of immunoprecipitates (IP) and [3H]-palmitate incorpora-
tion were shown.atalyze the exogenously expressed AMPA receptor
almitoylation in HEK 293T cells. Generally, PAT palmi-
oylation occurs on sulfhydryl groups of intracellular
ysteine residues in target proteins. To examine whether
3H]palmitate was linked to the receptor subunits via
ydroxylamine-sensitive thioester linkage to cysteines
Bizzozero, 1995), duplicate immunoprecipitated sam-
les of [3H]palmitate-labeled GluR1 and GluR2 in HEK
93T cells were treated with hydroxylamine (NH2OH) or
ris-HCl buffer (Figure 1B). The [3H]palmitate labeling of
hese AMPA receptor subunits was eliminated by treat-
ent with hydroxylamine and not by Tris-HCl buffer, in-
icating that the labeling was due to palmitoylation at
ysteine residues via thioester bonds. Next, we deter-
ined the site of palmitoylation using site-specific mu-
agenesis. One cysteine is conserved in the C-terminal
ntracellular region of all of the AMPA receptor subunits
n the juxtamembrane region just past TMD 4 (GluR1-
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(Figure 1C). To test whether this cysteine was the site
of palmitoylation, we generated four AMPA receptor
subunit mutants, GluR1C811S, GluR2C836S, GluR3C841S,
and GluR4C817S, in which cysteines were replaced
with serines. Labeling experiments with [3H]palmitic
acid showed that these CS mutants were not palmitoy-
lated, whereas the wild-types of all four AMPA receptor
subunits were palmitoylated in transfected HEK 293T
cells (Figure 1D). These data indicated that the AMPA
receptor subunits GluR1–GluR4 were palmitoylated on
cysteine residues within a homologous C-terminal re-
gion just after the TMD 4.
Palmitoylation of the AMPA Receptor in its
Transmembrane Domain 2 by GODZ
Genetic studies have revealed that the Erf2, Akr1, and
Ykt6 genes encoded PATs in yeast (Dietrich et al., 2004;
Dietrich and Ungermann, 2004; Lobo et al., 2002; Roth
et al., 2002). Erf2 and Akr1 have an aspartate-histidine-
histidine-cysteine (DHHC)-cysteine rich domain, which
is conserved in proteins from yeast to mammals. Re-
cently, a Golgi apparatus-specific protein with a DHHC
zinc finger domain (GODZ) was reported to have PAT
activity for the GABAA receptor (Keller et al., 2004;
Uemura et al., 2002). Thus, we examined the possibility
that GODZ may also function as a neuronal PAT for the
AMPA receptor. Palmitoylation of GluR2 was enhanced
by coexpression of GODZ in HEK 293T cells (Figure
2A). Moreover, although mutation of GluR2 on C836
(GluR2C836S) eliminated the palmitoylation of GluR2 in
the absence of GODZ expression, this mutation did not
eliminate palmitoylation of GluR2 in the presence of
GODZ expression (Figure 2A), indicating that palmitoy-
lation of an additional site was increased by GODZ.
There is only one other intracellular cysteine residue in
GluR2 (GluR2C610), which, interestingly, is located just
past TMD 2, the ion channel-forming region of the re-
ceptor subunit (Figure 2B). This site is just three amino
acids past the Q/R editing site that is critical for regula-
tion of ion channel function (Hollmann and Heinemann,
1994). This cysteine is also conserved on GluR1–4
(GluR1C585, GluR2C610, GluR3C615 and GluR4C611)
(Figure 2B). To test whether palmitoylation of this site
is regulated by GODZ, we generated a double mutant
in which both GluR2C610 and GluR2C836 were mu-
tated to serine residues (GluR2C610SC836S) and co-
expressed them with GODZ. Labeling experiments
with [3H]palmitic acid showed that the double mutant
GluR2C610SC836S was not palmitoylated, although
the single mutant GluR2C836S was palmitoylated in the
presence of GODZ expression (Figure 2C). Similar re-
sults were obtained for the GluR1CS mutant in its
C-terminal region (GluR1C811S) and for the GluR1
double CS mutant containing mutations in both the
TMD 2 and C-terminal region (GluR1C585SC811S) (Fig-
ures 2D and 2E). Namely, GluR1C811S was palmitoy-
lated by GODZ (Figure 2D), and GluR1C585SC811S
was not palmitoylated (Figure 2E). These data indicated
that overexpression of GODZ induced the palmitoyla-
tion of cysteine residue in the TMD 2 region of AMPA
receptor subunits. Disruption of the aspartate-histi-
dine-histidine-cysteine (DHHC) motif in the yeast Erf2and Akr1 PATs inhibit their PAT activities (Lobo et al.,
2002; Roth et al., 2002). We therefore made an analo-
gous aspartate-histidine-histidine-serine (DHHS) mu-
tant in GODZ and measured its PAT activity for AMPA
receptor subunits. This GODZ DHHS mutant lost its PAT
activity for the cysteines on TMD 2 of GluR2C836S (Fig-
ure 2F) and GluR1C811S (Figure 2G) in transfected HEK
293T cells. GODZ protein has an autopalmitoylation ac-
tivity in transfected HEK 293T cells, and the DHHS mu-
tant lacked the activity (Figure S1 in the Supplemental
Data available with this article online), confirming that
these mutations inhibit GODZ activity.
Functional Assembly of GluR1/GluR2 CS Mutants
The physical and functional assembly of wild-type and
CS mutants was examined in transfected HEK 293T cells
using biochemical (Figures 3A and 3B) and electrophysio-
logical (Figure 3C) techniques. First, GluR1 wild-type and
GluR2 wild-type, GluR2C610S, or GluR2C836S were co-
transfected into HEK 293T cells, and GluR1/GluR2
association was examined by coimmunoprecipitation
with anti-GluR1 antibodies from cell lysates for each
combination (Figure 3A). The result showed that muta-
tion of both palmitoylated cysteines on GluR2 (C610S
and C836S) had no effect on the heteromeric assembly
of the GluR1/GluR2 AMPA receptor. Similar results were
obtained for coimmunoprecipitation of GluR1CS mu-
tant (C585S and C811S) with GluR2 wild-type (Figure
3B). Furthermore, to test the functional consequences
of cysteine mutants in either the pore or tail region of
GluR1 and GluR2, we measured the current-voltage
(I-V) relationship of GluR1/GluR2 heteromers. GluR1
homomeric channels exhibited a characteristic inward
reactivation when expressed in HEK 293T cells (Figure
3C), similar to findings in other published reports (Ver-
doorn et al., 1991). However, a linear I-V relationship
was observed in cells expressing both GluR1 and
GluR2, indicating assembly of functional GluR1/GluR2
heteromeric channels (Figure 3C). We also observed
linear I-V relationships from cells expressing both
GluR1C585S/GluR2C610S and GluR1C811S/GluR2C836S
(Figure 3C), suggesting that CS mutations do not dis-
rupt functional heteromeric assembly of AMPA recep-
tors in heterologous expression systems.
Suppression of AMPA Receptor Surface
Expression by GODZ-Regulated
TMD 2 Palmitoylation
The expression of GODZ is concentrated in the Golgi
apparatus, suggesting that AMPA receptor palmitoyla-
tion may regulate receptor membrane trafficking during
biosynthesis (Keller et al., 2004; Uemura et al., 2002).
To examine whether GODZ-stimulated palmitoylation
affected the surface expression of AMPA receptors, we
used cell surface biotinylation techniques. Surface-
expressed proteins were biotinylated on ice for 20 min
and then biotinylated proteins were separated by avidin
beads. Coexpression of GODZ with GluR2 dramatically
inhibited the surface expression of GluR2. In contrast,
coexpression of the GODZ DHHS mutant had no effect
on GluR2 surface expression in transfected HEK 293T
cells (Figure 4A). Similarly, coexpression of GODZ de-
creased GluR1 surface expression, while the GODZ
Neuron
712Figure 2. Palmitoylation of the AMPA Receptor Subunits by the Palmitoyl Acyl Transferase GODZ
(A) Palmitoylation of GluR2 and the GluR2C836S mutant by exogenous palmitoyl acyl transferase GODZ in transfected HEK 293T cells (n =
3; Student’s t test, **p < 0.01, compared with GODZ-free). (B) Amino acid sequence of AMPA receptor subunits GluR1–4 in their transmem-
brane domain (TMD) 2. An arrow indicates conserved cysteine residues. (C) Identification of the GODZ palmitoylation site on GluR2.
GluR2C836S and GluR2C610SC836S were labeled with [3H]palmitate in transfected HEK 293T cells. (D) Palmitoylation of GluR1 and
GluR1C811S mutant by GODZ in transfected HEK 293T cells (n = 3; Student’s t test, *p < 0.05, compared with GODZ-free). (E) Identification
of the GODZ palmitoylation site on GluR1. GluR1C811S and GluR1C585SC811S were labeled with [3H]-palmitate in transfected HEK 293T
cells. (F) Palmitoylation of GluR2C836S by GODZ or GODZ mutant (DHHS) in transfected HEK 293T cells. (G) Palmitoylation of GluR1C811S
by GODZ or GODZ mutant (DHHS) in transfected HEK 293T cells. (A and C–G) Immunoprecipitation (IP) and detection of incorporated [3H]-
palmitate or IP and Western blotting (WB) with anti-GluR antibodies were shown (top). Expression of each protein was confirmed by Western
blotting (WB) (bottom). Error bars indicate the mean ± SEM.DHHS mutant had no effect (Figure 4B). To examine
whether the GluR2 TMD 2 (GluR2C610) palmitoylation
site mediated this effect, we coexpressed GODZ with
the GluR2C610S mutant. Interestingly, when expressed
alone, the GluR2C610S mutant showed slightly in-
creased surface expression in HEK 293T cells, com-
pared with GluR2 wild-type (Figure 4C). Similar results
were observed in the surface expression of GluR1 and
GluR1C585S (Figure 4D). GluR1C585S showed greater
surface expression than GluR1 wild-type in HEK 293T
cells. Moreover, the surface expression of GluR2C610S
(Figure 4E) and GluR1C585S (Figure 4F) was not influ-
enced by coexpression with GODZ or the GODZ DHHS
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dutant. To examine whether this regulation also oc-
urred in neurons, we analyzed whether GODZ sup-
ressed the surface expression of endogenous AMPA
eceptors in low-density cortical cultured neurons (Fig-
re 4G). Cortical cultured neurons were transfected
ith GODZ-GFP or GODZ(DHHS)-GFP, and the surface
xpression of endogenous GluR1 was measured by live
taining with polyclonal anti-GluR1 N-terminal antibod-
es, followed by labeling with Cy3-conjugated anti-rab-
it IgG antibodies. While the GODZ DHHS mutant had
o effect on GluR1 surface expression, GODZ wild-type
ramatically reduced GluR1 surface expression. This
ata suggests that GODZ-induced palmitoylation of the
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713Figure 3. Association of GluR1 and GluR2 CS Mutants
(A) Coimmunoprecipitation of GluR2 wild-type and GluR2 CS mu-
tants (C610S and C836S) with GluR1 in lysates from transfected
HEK 293T cells. Immunoprecipitation (IP) with anti-GluR1 antibod-
ies and Western blotting (WB) with anti-GluR1 or anti-GluR2
antibodies were shown (top). Expression of each protein was con-
firmed by Western blotting (WB) (bottom). (B) Coimmunoprecipita-
tion of GluR1 wild-type and GluR1 CS mutants (C585S and C811S)
with GluR2 in lysates from transfected HEK 293T cells. Immuno-
precipitation (IP) with anti-GluR2 antibodies and Western blotting
(WB) with anti-GluR1 or anti-GluR2 antibodies were shown (top).
Expression of each protein was confirmed by Western blotting
(WB) (bottom). (C) Current-voltage (I-V) relationship of AMPA recep-
tors arising from several wild-type and mutant subunit combina-
tions. Traces are averages of five or more individual recordings. The
normalized current was obtained by dividing the ramped current by
the initial current measured at −70 mV.cysteine in the TMD 2 region of AMPA receptor sub-
units inhibits surface expression.
Accumulation of the TMD 2-Palmitoylated AMPA
Receptor in the Golgi Apparatus
To analyze this in more detail, we next examined the
effect of GODZ on GluR2 subcellular expression using
immunocytochemical techniques. We first examined
the colocalization of myc-tagged GODZ and myc-
tagged GODZ DHHS with a Golgi apparatus marker,
GM-130 (Figure 5A). Both GODZ and GODZ DHHS colo-
calized with GM-130 and were concentrated in the
Golgi apparatus in transfected HEK 293T cells. Co-transfection experiments using GluR2 and GluR2C610S
with or without GODZ and GODZ DHHS mutant showed
that GluR2 was concentrated in the Golgi apparatus
only when it was coexpressed with wild-type GODZ,
while GluR2 alone, GluR2 with GODZ DHHS mutant,
and GluR2C610S with or without GODZ, had a more
diffuse expression pattern (Figure 5B). The majority of
GluR2 was colocalized with GODZ, when it was co-
expressed with wild-type GODZ, but not with the
GODZ DHHS mutant (Figure 5C, top). In contrast, the
GluR2C610S mutant did not colocalize with GODZ (Fig-
ure 5C, bottom). These data demonstrate that palmitoy-
lation of the AMPA receptor subunits on their TMD 2
accumulates the receptor in the Golgi apparatus and
suggest that depalmitoylation may be a trigger for re-
ceptor trafficking to the cell surface.
Normal Localization of the C-Terminal Palmitoylated
AMPA Receptor on the Cell Surface
To reveal the biological function of AMPA receptor
C-terminal palmitoylation, we investigated whether pal-
mitoylation affected the membrane trafficking of the
AMPA receptor in HEK 293T cells and neurons. Wild-
type and C-terminal CS mutants of GluR2 were trans-
fected into HEK 293T cells in the absence of GODZ.
Compared with GluR2WT, GluR2C836S showed equal
surface expression (Figure 6A). This result suggests
that the steady-state cell surface expression is not in-
fluenced by receptor C-terminal palmitoylation. We
then examined the surface expression of N-terminal
GFP-tagged GluR1 and GluR2 (GFP-GluR1WT and
GFP-GluR2WT) and their palmitoylation-deficient mu-
tants (GFP-GluR1C811S and GFP-GluR2C836S) in neu-
rons. These constructs were transfected into cortical
cultured neurons by the calcium phosphate method
and examined 5 to 7 days after transfection (Hayashi
and Huganir, 2004). First, GFP clustering along the den-
drites was measured to determine the steady-state ex-
pression pattern. The results showed that there was no
significant difference in the numbers of GFP clusters
along the dendrites between wild-types and C-terminal
CS mutants (Figure 6B). Then, surface GFP-GluR1 and
GFP-GluR2 subunits were live stained with polyclonal
anti-GFP antibodies, followed by addition of Cy3-con-
jugated anti-rabbit IgG secondary antibodies to visual-
ize surface expression. The ratio of Cy3-red to GFP-
green fluorescence intensities indicated the proportion
of surface to total GFP. Mutation of the C-terminal pal-
mitoylation site in both GFP-GluR1 and GFP-GluR2 did
not alter the surface expression ratio (Figure 6C). These
results suggest that steady-state surface expression of
the AMPA receptor is not influenced by direct receptor
C-terminal palmitoylation in neurons.
Palmitoylation-Dependent AMPA Receptor
Internalization
We then examined the effect of mutation of the C-ter-
minal palmitoylation sites on activity-dependent in-
duced internalization of GFP-GluR1/2. Recent studies
have revealed that AMPA receptor endocytosis is in-
creased following AMPA or NMDA treatment of neurons
(Beattie et al., 2000; Carroll et al., 2001, 1999; Lin et
al., 2000). Surface expression of the GFP-GluR1/GFP-
Neuron
714Figure 4. GODZ-Mediated Suppression of AMPA Receptor Surface Expression
(A and B) Effect of GODZ or GODZ dead mutant (DHHS) on GluR2 (A) and GluR1 (B) surface expression in transfected HEK 293T cells (n = 3;
Student’s t test, **p < 0.01 and ***p < 0.001, compared with GODZ-free). (C and D) Surface expression of GluR2 and GluR2C610S mutant (C)
and GluR1 and GluR1C585S mutant (D) in transfected HEK 293T cells (n = 3; Student’s t test, *p < 0.05, compared with wild-type). (E and F)
Effect of GODZ or GODZ dead mutant (DHHS) on GluR2C610S (E) and GluR1C585S (F) surface expression in transfected HEK 293T cells. (A–F)
Biotinylated surface GluR1 or GluR2 (top) and total GluR1, GluR2, or myc-GODZ protein expression (bottom) were examined by western
blotting with each antibody. (G) Surface expression of endogenous GluR1 in GODZ-GFP transfected cortical cultured neurons. Typical expres-
sion patterns of surface GluR1 and GODZ-GFP or GODZ(DHHS)-GFP were shown (left). Quantified data of surface expression of endogenous
GluR1 (right, n = 14, n = 9, and n = 10, respectively, Student’s t test, ***p < 0.001, compared with control). Error bars indicate the mean ± SEM.GluR2 and of the GFP-GluR1C811S/GFP-GluR2C836S
mutant in transfected cortical neurons was measured
by live staining of neurons with anti-GFP antibodies,
a
A
(nd the neurons were then stimulated with 100 M
MPA for 10 min or 50 M NMDA for 2–3 min in media
total incubation time equaled 10 min at 37°C). After
Palmitoylation of AMPA Receptor Subunits
715Figure 5. GODZ-Mediated Accumulation of AMPA Receptors in the Golgi Apparatus
(A) Colocalization of myc-GODZ or myc-GODZ(DHHS) with the Golgi apparatus marker GM-130, in transfected HEK 293T cells.
(B) Colocalization of GluR2 with the Golgi apparatus marker GM-130 in HEK 293T cells transfected with GluR2 or GluR2C610S with or without
myc-GODZ or myc-GODZ(DHHS).
(C) Colocalization of GluR2 with GODZ in HEK 293T cells transfected with GluR2 or GluR2C610S with or without myc-GODZ or myc-
GODZ(DHHS).stimulation, the cortical neurons were fixed, and the re-
maining surface anti-GFP antibodies were blocked by
incubation with goat anti-rabbit IgG F(ab’)2 fragments.
The fixed neurons were then permeabilized, and the
internalized anti-GFP antibodies were visualized by
staining with Cy3-conjugated goat anti-rabbit IgG anti-
bodies. Representative patterns of internalized GFP-
GluR1WT and GFP-GluR1C811S receptors (Figure 7A,
left) and GFP-GluR2WT and GFP-GluR2C836S recep-
tors (Figure 7B, left) are shown. The ratio of the average
intensity of internalized anti-GFP antibodies (Cy3-red
intensity) to that of total GFP-GluR level (GFP-green in-
tensity) was calculated. The results showed that both
AMPA and NMDA stimulation enhanced the internaliza-
tion of GFP-GluR1/2, whereas the internalization of the
mutant GFP-GluR1/2CS subunits was not increased by
agonist stimulation (Figures 7A and 7B, right). Constitu-
tive internalization was not changed between wild-type
and palmitoylation-deficient mutant (GFP-GluR1/2WT
and GFP-GluR1/2CS controls, respectively). These re-
sults show that the AMPA receptor C-terminal palmi-
toylation regulates stimulation-dependent endocytosis
of AMPA receptors.Association of Nonpalmitoylated AMPA
Receptors with 4.1N
The C-terminal palmitoylation site overlaps with the re-
gion of the AMPA receptor subunits that bind the cy-
toskeletal protein 4.1N (Coleman et al., 2003; Shen et
al., 2000). 4.1N is a neuron-enriched homolog of the
erythrocyte membrane cytoskeletal protein 4.1R (Wa-
lensky et al., 1999), which was originally identified in
red blood cells and has another ubiquitously expressed
homolog, 4.1G (Walensky et al., 1999). 4.1 is critical for
the organization and maintenance of the spectrin/actin
cytoskeleton and for the attachment of the cytoskele-
ton to the cell membrane through interaction with inte-
gral membrane proteins (Anderson and Lovrien, 1984;
Pasternack et al., 1985; Tyler et al., 1979). 4.1N has a
spectrin/actin binding domain and a C-terminal domain
that binds a C-terminal 11 amino acid stretch present
just after TMD 4 in all AMPA receptor subunits (Cole-
man et al., 2003; Shen et al., 2000) (Figure S2). To exam-
ine the effect of palmitoylation on receptor interaction
with 4.1N, the wild-type and the C-terminal palmitoyla-
tion-deficient mutant of GluR1 were cotransfected with
the myc-tagged 4.1N C-terminal domain (myc-4.1N
Neuron
716Figure 6. Palmitoylation of the C-Terminal Region Has No Effect on the Steady-State Cellular Distribution of AMPA Receptors
(A) The effect of mutation at the GluR2 C-terminal palmitoylation site (C836S) on surface receptor expression in HEK 293T cells. Biotinylated
surface GluR2 (top) and total GluR2 protein expression (bottom) were examined by immunoblotting with anti-GluR2 antibody.
(B) GFP signals of GFP-GluR1/2 and GFP-GluR1/2CS clusters in cortical cultured neurons. Typical patterns of GFP-fluorescence were shown
(left). Cluster numbers along the dendrites ([right], GluR1, n = 10 and n = 10, respectively; Student’s t test, p > 0.5 and GluR2, n = 9 and n =
10, respectively; Student’s t test, p > 0.48). Error bars indicate the mean ± SEM.
(C) Surface expression of GFP-GluR1/2 and GFP-GluR1/2CS in cortical cultured neurons. Typical patterns of surface GFP were shown (left).
Ratio of surface to total GFP expression ([right], GluR1, n = 12 and n = 12, respectively; Student’s t test, p > 0.97 and GluR2, n = 10 and n =
12, respectively; Student’s t test, p > 0.75). Error bars indicate the mean ± SEM.CTD) or a smaller highly conserved C-terminal region
(myc-4.1N CTDc) into HEK 293T cells. A previous report
showed that these domains within 4.1N were responsi-
ble for binding to GluR1 (Shen et al., 2000). Coimmuno-
precipitation experiments with the anti-Myc antibody
revealed that the GluR1C811S mutant showed a
stronger association with both 4.1N CTD and 4.1N
CTDc than did GluR1 wild-type in transfected HEK
293T cells (Figure 8A). In addition, treatment with 100

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TM 2-bromo palmitate (2-Br PA), a general inhibitor of
almitoylation, increased the interaction of 4.1N CTD
ith GluR1 wild-type, whereas 2-Br PA had little effect
n its interaction with GluR1C811S (Figure 8B). To in-
estigate the potential functional consequences of this
inding, the effect of the 4.1N CTD protein on the sur-
ace expression of GFP-GluR1 and GFP-GluR1C811S
as examined in cortical cultured neurons (Figure 8C).
he 4.1N CTD lacks the ability to bind spectrin/actin
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717Figure 7. Palmitoylation of the C-Terminal Region Regulates AMPA- and NMDA-Induced Internalization of GFP-GluR1 and GFP-GluR2
(A) Typical patterns of AMPA- or NMDA-induced internalization of GFP-GluR1 (WT) and GFP-GluR1C811S mutant (C811S) in transfected
cortical cultured neurons were shown (left). The ratios of fluorescence intensities of internalized anti-GFP antibodies (visualized by Cy3-
conjugated anti-rabbit IgG) to total GFP expressions (green fluorescent signal of GFP) were shown (right). AMPA- or NMDA-induced internal-
ization of GFP-GluR1 and GFP-GluR1C811S mutant in transfected cortical cultured neurons (six bars [WT]: n = 14, n = 14, n = 16, [C811S]
n = 13, n = 11, n = 11 respectively, F = 6.08, p < 0.01, ANOVA). (B) Typical patterns of AMPA- or NMDA-induced internalization of GFP-GluR2
(WT) and GFP-GluR2C836S mutant (C836S) in transfected cortical cultured neurons were shown (left). The ratios of fluorescence intensities
of internalized anti-GFP antibodies (visualized by Cy3-conjugated anti-rabbit IgG) to total GFP expressions (green fluorescent signal of GFP)
were shown (right). AMPA- or NMDA-induced internalization of GFP-GluR2 and GFP-GluR2C836S mutant in transfected cortical cultured
neurons (six bars [WT]: n = 9, n = 10, n = 10, (C836S) n = 10, n = 5, n = 10 respectively, F = 4.81, p < 0.01, ANOVA). *p < 0.05, **p < 0.01,
ANOVA, compared with control. Error bars indicate the mean ± SEM.and thus cannot crosslink GluR1 to the spectrin/actin
cytoskeleton (Shen et al., 2000). Surface-expressing
GFP was live stained with polyclonal anti-GFP antibod-
ies, followed by labeling with Cy3-conjugated anti-rab-
bit IgG antibodies to visualize surface expression. As
shown in Figure 6C, the ratio of Cy3-red to GFP-green
fluorescence intensity indicated the proportion of the
transfected receptor present on the cell surface. Coex-
pression of 4.1N CTD suppressed the surface expres-
sion of the GluR1C811S mutant, but had no influence
on GluR1 wild-type, suggesting that dominant negative
4.1N CTD interrupted the surface expression of nonpal-
mitoylated GluR1, but not palmitoylated GluR1, and
that this surface expression likely required the 4.1N
with spectrin/actin.Glutamate-Induced Depalmitoylation
of the AMPA Receptor
To analyze palmitoylation of the endogenous AMPA re-
ceptor in vivo, we labeled cortical cultured neurons with
[3H]palmitic acid. Experiments with [3H]palmitate label-
ing showed that endogenous GluR1 and GluR2 were
palmitoylated in cortical cultured neurons (Figure 9A).
Palmitoylation of the NMDA receptor subunit NR1 was
not observed in the same condition. Because of the
sequence similarity around the palmitoylation sites of
all four AMPA receptor subunits GluR1–GluR4, we fo-
cused on endogenous GluR1 and GluR2 palmitoylation
as representative of these receptor subunits. Recent
studies showed that PSD-95 was depalmitoylated when
the hippocampal neurons were stimulated by 10 M glu-
Neuron
718Figure 8. Regulation of the Association of
AMPA Receptors with the 4.1N Protein by
C-Terminal Palmitoylation.
(A) Association of GluR1 and GluR1CS with
myc-4.1N CTD or myc-4.1N CTDc in HEK
293T cells. Coimmunoprecipitations (IP) were
performed on solubilized cell lysates using
the anti-Myc antibody, followed by Western
blotting (WB) with each antibody (left, top).
Expression of each protein was confirmed
by immunoblots of cell lysates probed with
anti-GluR1 or anti-Myc antibodies (left, bot-
tom). Quantified data of the ratio of GluR1 to
4.1N CTD in immunoprecipitates (right, n =
3, respectively; Student’s t test, **p < 0.01,
compared with WT). (B) The effect of 2-bromo
palmitate (2-Br PA) on the association of
GluR1 and GluR1CS with myc-4.1N CTD in
HEK 293T cells. Transfected cells were
treated with 100 M 2-Br PA for 24 hr. Coim-
munoprecipitations (IP) were performed on
solubilized cell lysates using anti-Myc anti-
body, followed by Western blotting (WB) with
each antibody (left, top). Expression of each
protein was confirmed by immunoblots of
cell lysates probed with anti-GluR1 or anti-
Myc antibodies (left, bottom). Quantified
data of the ratio of GluR1 to 4.1N CTD in the
immunoprecipitates (right, n = 3; Student’s t
test, *p < 0.05, compared with WT). (C) Sur-
face expression of GFP-GluR1 and GFP-
GluR1C811S with or without 4.1N CTD in
cortical cultured neurons. Typical patterns of
surface GFP were shown (left). Quantified
data of ratios of surface to total GFP expres-
sion (right panel, n = 12, n = 10, n = 13, n =
10 [left to right bars, respectively]; Student’s
t test, *p < 0.05). Error bars indicate the
mean ± SEM.tamate for 1 hr (El-Husseini et al., 2002). Using anti-
GluR1 and anti-GluR2 antibodies, stimulation-depen-
dent changes of endogenous GluR1/2 palmitoylation
were then studied. Treatment of neurons with glutamate
(10 M, 1 hr at 37°C) decreased the palmitoylation of
GluR1/2 without affecting total GluR1/2 protein amounts
(Figure 9B). These results indicate that, similar to the
palmitoylation of PSD-95, activation of GluRs can regu-
late AMPA receptor palmitoylation.
Discussion
Post-translational palmitoylation of proteins is a revers-
ible process that is regulated by the balance of PAT and
PTE activity (Bijlmakers and Marsh, 2003; El-Husseini
and Bredt, 2002). Palmitoylation of proteins plays im-
portant roles in regulating the membrane trafficking of
proteins and in regulating protein activity. Here, we
show that AMPA receptor subunits are palmitoylated
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mn vitro and in vivo. The AMPA receptor subunits GluR1–4
re palmitoylated at a C-terminal cysteine that lies just
fter the final transmembrane domain and also at a cys-
eine in their TMD 2 region. Palmitoylation of this sec-
nd site is increased by the Golgi apparatus-specific
AT GODZ. There appears to be no strict consensus
n the precise amino acid sequence requirement for
almitoylation, though recent studies have shown that
asic residues and hydrophobic residues are frequently
bserved adjacent to many palmitoylated cysteines
Bijlmakers and Marsh, 2003; El-Husseini and Bredt,
002; Gauthier-Campbell et al., 2004). Moreover, palmi-
oylation of transmembrane proteins often occurs at in-
racellular cysteines adjacent to transmembrane do-
ains (Bijlmakers and Marsh, 2003; El-Husseini and
redt, 2002). The C-terminal site is near TMD 4 and is
urrounded by basic and hydrophobic residues, while
he TMD 2 site is contained within a hydrophobic trans-
embrane region with neighboring basic residues. We
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719Figure 9. Glutamate-Stimulated Depalmitoy-
lation of AMPA Receptor Subunits GluR1
and GluR2
(A) Palmitoylation of endogenous GluR1,
GluR2, and NR1 in cortical cultured neurons.
Sister cortical cultured neurons were incu-
bated with [3H]palmitate for 24 hr and were
then immunoprecipitated with either the
specific antibody or control IgG. The incor-
porated [3H]-palmitate signals were shown
(top). Immunoprecipitation (IP) with each an-
tibody and total protein expression (cell ly-
sate) were confirmed by Western blotting
(WB) (middle, bottom).
(B) Glutamate-induced change of GluR1 and
GluR2 palmitoylation. Cortical cultured neu-
rons were treated with 10 M glutamate for
1 hr at 37°C in 100 M APV-containing me-
dia. A representative example of an IP with
each anti-GluR antibody and [3H]palmitate
incorporation (top) or IP and WB with each
anti-GluR antibody (middle) were shown.
Quantified data of the ratio of [3H]palmitate-
labeled GluR to the total GluR protein
amount (bottom, left, n = 4, respectively; Stu-
dent’s t test, *p < 0.05 and **p < 0.01, com-
pared with control) and immunoprecipitated
(IP) GluR protein amount (bottom, right, n =
4). Error bars indicate the mean ± SEM.show that the AMPA receptor subunits were palmitoy-
lated both in cortical neurons and transfected HEK
293T cells by endogenous PATs. Stimulation of the cor-
tical cultured neurons with glutamate (10 M, 1 hr at
37°C) induced depalmitoylation of the AMPA receptor,
suggesting that glutamate receptor activation regulates
PTE and/or inhibits PAT activity.
Mammalian PATs have only recently been identified
(Fukata et al., 2004; Huang et al., 2004). In this paper,
we demonstrate that the PAT GODZ increases the pal-
mitoylation of the AMPA receptor subunits on their TMD
2 site. Although it is likely that GODZ directly palmitoy-
lates the TMD 2 site, we cannot rule out the possibility
that other PATs may also palmitoylate this site. Which
PAT palmitoylates the C-terminal site, however, is un-
clear and its identification will require a systematic
analysis involving palmitoylation of this site by the
other mammalian PATs. GODZ is localized in the Golgi
apparatus, and palmitoylation of AMPA receptors on
the TMD 2 site promotes the accumulation of the re-
ceptor in the Golgi apparatus (Figure 10A). Interestingly,
TMD 2 encodes the channel region of AMPA receptors
and the palmitoylation site occurs three amino acids
away from the Q/R editing site that plays a critical rolein the regulation of the calcium permeability and rectifi-
cation properties of AMPA receptors (Hollmann and
Heinemann, 1994). Moreover, editing of the Q/R site has
been shown to regulate the exit of the GluR2 subunit
from the ER (Greger et al., 2003). As palmitoylation of
this site occurs in the Golgi apparatus after assembly
of the subunits into a tetramer in the ER, this modifica-
tion adds another potential layer of regulation in the
trafficking of the receptor to the cell’s surface. The de-
tailed molecular mechanism for receptor trapping by
palmitoylation of the TMD 2 site is not clear, but depal-
mitoylation of this cysteine may be critical for release
of the receptor from the Golgi apparatus for surface de-
livery.
In contrast to palmitoylation of the TMD 2 site, palmi-
toylation of the C-terminal site had no effect on the
steady-state surface expression of the AMPA receptor
subunits. However, palmitoylation of this site regulates
agonist-induced internalization of the receptor by
AMPA and NMDA. The C-terminal cysteine is located in
a region that we and others have previously found to
be important for binding to the 4.1N protein (Coleman
et al., 2003; Shen et al., 2000). Binding of GluR1 to 4.1N
regulates its surface expression, suggesting that 4.1N
Neuron
720Figure 10. Model of the Role of AMPA Receptor Palmitoylation
(A) GODZ increases palmitoylation of AMPA receptors on the TMD
2 site and regulates receptor accumulation in the Golgi apparatus.
Depalmitoylation of the TMD 2 site may regulate release of AMPA
receptors from the Golgi for surface delivery.
(B) Depalmitoylation of the AMPA receptor on the C-terminal site
increases the receptors’ affinity for 4.1N, which stabilizes receptors
at the cell surface by the interaction of 4.1N with F-actin and spec-
trin. (C) In contrast, the palmitoylated forms of surface AMPA re-
ceptors are less stably associated with the plasma membrane and
are more susceptible to AMPA- and NMDA-induced internalization.
The balance of depalmitoylated and palmitoylated forms of the re-
ceptor can be regulated by long-term glutamate treatment (60 min),
suggesting that synaptic activity can regulate the steady-state level
of receptor palmitoylation.
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clinks AMPA receptors to the actin cytoskeleton and
maintains receptor surface expression (Shen et al.,
2000). In this study, we demonstrate that the C-terminal
nonpalmitoylated CS mutant of GluR1 has a stronger
association with 4.1N than does the wild-type GluR1.
Furthermore, we show that the binding of 4.1N and
wild-type GluR1, but not that of 4.1N with the C-ter-
minal CS mutant, was enhanced by 2-bromo palmitate
treatment and that surface expression of nonpalmitoy-
lated GFP-GluR1C811S was decreased by coexpres-
sion of a dominant negative form of 4.1N. A previous
study from our laboratory demonstrated that coexpres-
sion of the dominant negative form of 4.1N in COS cells
inhibited the surface expression of a C-terminal trunca-
tion mutant of GluR1 that still contained the C-terminal
palmitoylation site (Shen et al., 2000). It is possible that
the differences observed in these results are due to the
fact that we analyzed the surface expression of full-
length GluR1 in neurons in the current experiments in
contrast to the examination of the surface expression
of a truncated form of GluR1 in COS cells in the previ-
ous experiments. Alternatively, it is possible that the
truncated GluR1 subunit (truncated at amino acid 823)
is not palmitoylated, even though it still contains the
palmitoylation cysteine (C811). The data presented in
this paper suggest that the nonpalmitoylated form of
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fhe receptor is more tightly associated with F-actin/
pectrin through 4.1N (Figure 10B). While both palmi-
oylated and nonpalmitoylated forms of AMPA recep-
ors are presumably regulated by many receptor bind-
ng proteins in vivo, these results suggest that the actin
ytoskeleton may play a more prominent role in stabiliz-
ng the surface nonpalmitoylated AMPA receptors.
The C-terminal palmitoylation-deficient mutants of
luR1 and GluR2 showed normal clustering and sur-
ace expression in both cortical neurons and HEK 293T
ells. However, surface expression of the AMPA recep-
or in cortical cultured neurons was decreased by treat-
ent with a general palmitoylation inhibitor, 2-bromo
almitate (data not shown and [El-Husseini et al.,
002]). Previous studies showed that clustering of sur-
ace AMPA receptors at synapses is enhanced by pal-
itoylated PSD-95 (El-Husseini et al., 2000a, 2002),
hich forms a complex with the AMPA receptor and
targazin family proteins (Tomita et al., 2003, 2004; Van-
enberghe et al., 2005). In addition, several AMPA re-
eptor-interacting molecules that regulate the targeting
f AMPA receptors are palmitoylated (Craven et al.,
999; DeSouza et al., 2002; El-Husseini et al., 2000a,
000b, 2002; Topinka and Bredt, 1998; Yamazaki et al.,
001). Our data show that surface expression of the
MPA receptor is not directly affected by AMPA recep-
or C-terminal palmitoylation, but that AMPA- and
MDA-induced acute receptor internalization is regu-
ated by receptor C-terminal palmitoylation (Figure
0C). In addition, we found that palmitoylation of the
MD 2 site has a profound effect on the delivery of the
eceptor to the surface from the Golgi. Thus, palmitoy-
ation of AMPA receptor-interacting molecules and
MPA receptors themselves play distinct roles in the
egulation of the membrane trafficking of AMPA re-
eptors.
xperimental Procedures
rimary Neuron Culture, HEK 293T Cells, and Transfection
igh- and low-density cortical cultured neurons were prepared as
reviously described (Hayashi and Huganir, 2004). Cortical cultured
eurons (106 cells per lane) were used 3–4 weeks after plating for
iochemical experiments. At 14–16 days in vitro (DIV), cortical cul-
ured neurons on coverslips were used for GFP-GluR1/2 or
cDNA3-GODZ-GFP transfection. HEK 293T cells (107 cells per
ane) were transfected with wild-type and mutants of GluR1, 2, 3,
, and 6 or pRK5-myc-4.1N CTD and pRK5-myc-4.1N CTDc or
cDNA3-myc-GODZ (CMV promoter), using a calcium phosphate
ethod as described (Hayashi and Huganir, 2004).
nalysis of Palmitoylation
EK 293T cells were transiently transfected with GluR and Myc-
agged GODZ and metabolically labeled with [3H]palmitate (NEN, 1
Ci/ml) for 4–5 hr, 3 days after transfection. Cells were lysed in
IPA buffer (containing 10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1
M EDTA, 1% Triton X-100, 0.1% SDS, and 0.1% sodium de-
xycholate, 10 g/ml aprotinin, and 10 g/ml leupeptin) and immu-
oprecipitated with each anti-GluR antibody or anti-Myc antibody
9E10), respectively. Immunoprecipitated samples were separated
y 7.5% SDS-PAGE followed by Western blotting or X-ray film ex-
osure at −70°C for 3–12 days. For fluorography, gels were treated
ith Amplify (Amersham) for 30 min, dried under vacuum, and ex-
osed to Hyperfilm-MP (Amersham). In the hydroxylamine treat-
ent experiment, duplicate gels of labeled GluR1 and GluR2 puri-
ied from HEK 293T cells were treated with 1 M hydroxylamine
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721(NH2OH [pH, 7.0]) or 1 M Tris-HCl (pH, 7.0) for 18 hr at room temper-
ature, followed by exposure to film for 2 weeks as above.
Cortical cultured neurons were metabolically labeled with
[3H]palmitate (1 mCi/ml) for 24 hr. Neurons were lysed in RIPA
buffer and immunoprecipitated with anti-GluR1 (JH1816), anti-
GluR2 (Chemicon, MAB397) and anti-NR1 (JH4762) antibodies. Of
the total immunoprecipitated GluR, 10% were used for Western
blotting with each anti-GluR antibody to measure the immunopre-
cipitated GluR amount and 90% were used for [3H]palmitate-
labeled signal exposure at −70°C for 2–4 weeks. The ratio of the
[3H]-labeled GluR to the total immunoprecipitated GluR was then
normalized to control.
Coimmunoprecipitation of GluR1/GluR2 Wild-Type
and CS Mutants
HEK 293T cells were transfected with described combinations
with pRK5-myc-4.1N CTD, pRK5-myc-4.1N CTDc, pRK5-GluR1,
pRK5-GluR1C585S and pRK5-GluR1C811S, pRK5-GluR2, pRK5-
GluR2C610S, and pRK5-GluR2C836S (CMV promoter) by the cal-
cium phosphate method. Cells were lysed in RIPA buffers (Figures
3A and 3B) or TNE buffer (containing 50 mM Tris-HCl [pH, 8.0], 150
mM NaCl, 20 mM EDTA, 1% Triton X-100, 10 g/ml aprotinin, and
10 g/ml leupeptin) (Figures 8A and 8B) and immunoprecipitated
with anti-Myc (9E10), anti-GluR1 (JH1816), or anti-GluR2/3 (JH1707)
antibodies. Immunoprecipitated samples and cell lysates were sep-
arated by SDS-PAGE followed by Western blotting with anti-Myc
(9E10), anti-GluR1 (JH1816), or anti-GluR2 (Chemicon, MAB397)
antibodies.
Electrophysiological Analysis
HEK 293T cells were transfected with pRK5-GluR1 and pGFP-S65T
(at 2:1 ratio), pRK5-GluR1, pRK5-GluR2, and pGFP-S65T (at 1:1:1
ratio), pRK5-GluR1C585S, pRK5-GluR2C610S, and pGFP-S65T (at
1:1:1 ratio), or pRK5-GluR1C811S, pRK5-GluR2C836S, and pGFP-
S65T (at 1:1:1 ratio) by the calcium phosphate method at 6 g of
DNA per 10 cm plate. At w24 hr after transfection, the cells were
detached from the plates with PBS containing 5 mM EDTA and
were replaced on coverslips coated with 1 mg/ml poly-L-lysine.
Recordings were performed at room temperature (22–25°C) on sin-
gle, isolated GFP-positive cells at w48 hr after transfection. The
composition of extracellular saline (ES) was: 150 mM NaCl, 3.1 mM
KCl, 2 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES. The osmolarity
of ES was adjusted to 300 mOsm and the pH was 7.3–7.4. Intracel-
lular saline (IS) consisted of: 135 mM Cs-MeSO4, 10 mM CsCl, 10
mM HEPES, 5 mM EGTA, 2 mM MgCl2, 4 mM Na-ATP, 0.1 mM Na-
GTP, and 0.1 mM spermine. This saline was adjusted to 295 mOsm
and a pH of 7.2. Once achieving the whole-cell recording configura-
tion, HEK 293T cells were voltage-clamped at −70 mV for 2 min.
Voltage was then ramped to +40 mV at 55 mV*s−1 in the presence
and absence of AMPA (1–100 M) and cyclothiazide (100 M). Sub-
traction of the two traces resulted in the current-voltage relation-
ship of the various AMPA receptor subunit combinations.
Biotinylation Assay
For surface biotinylation, transfected HEK 293T cells were cooled
on ice, washed twice with ice-cold PBS containing 1mM CaCl2 and
5 mM MgCl2, and then incubated with PBS containing 1mM CaCl2,
5 mM MgCl2, and 1 mg/ml Sulfo-NHS-LC-Biotin (Pierce) for 20 min
at 4°C. Unreacted biotinylation reagent was removed by washing
cells three times with ice-cold TBS (50 mM Tris-HCl [pH, 7.5] and
150 mM NaCl). Cultures were harvested in RIPA buffer. Homoge-
nates were centrifuged at 15,000 × g for 20 min at 4°C. The resulting
supernatant was incubated with NeutrAvidin beads (Pierce) for 3 hr
at 4°C. Precipitates were analyzed by immunoblotting with each
antibody.
Immunocytochemical Experiments
Anti-GFP antibodies (JH4030) were raised against a GFP-fusion
protein. GFP-GluR cluster numbers were automatically counted
and analyzed with Metamorph software (Universal Imaging Corpo-
ration, West Chester, PA) after setting a threshold of fluorescent
intensity that was slightly higher than that in the dendritic shaft.
The number of clusters was normalized to the dendritic length afterall dendritic branches in an image were manually traced and mea-
sured. The upper threshold limit for this selection was used to ex-
clude the cell body and proximal dendritic shafts, which have much
larger area than spines do.
Internalized GFP-GluR was selectively visualized as follows. Sur-
face GFP-GluR was labeled by incubating live neurons for 20 min
at 10°C with anti-GFP antibodies. Following washout of the excess
antibodies, neurons were treated with 100 M AMPA or 50 M
NMDA at 37°C. After the stimulation, neurons were washed twice
with PBS containing 4% sucrose and then fixed with 4% paraform-
aldehyde and 4% sucrose in PBS (room temperature, 20 min). The
remaining surface anti-GFP antibodies were blocked with goat
anti-rabbit IgG F(ab’)2 fragments (Jackson Immunoresearch Lab).
Fixed neurons were permeabilized with PBS containing 0.2% Triton
X-100 (4°C, 15 min). Coverslips were blocked in 10% normal don-
key serum in PBS at 4°C overnight, and then internalized GFP-GluR
was visualized by staining with Cy3-conjugated anti-rabbit IgG
(Jackson Immunoresearch Lab.) diluted in 10% normal donkey se-
rum in PBS as the secondary antibodies. Fluorescence images
were acquired using a Photometrics CCD camera and quantified
with Metamorph. The fluorescence intensity averages of Cy3-red
and GFP-green signals in dendritic regions in the indicated num-
bers of different neurons were measured. Red fluorescence inten-
sity indicative of internalization was divided by green fluorescence
intensity to control for the GFP-GluR protein expression level. Units
of internalization were measured as a ratio of red/green fluores-
cence normalized to untreated controls. Surface expression of en-
dogenous GluR1 was measured by live staining with anti-GluR1
N-terminal antibodies (JH1816), followed by labeling with Cy3-con-
jugated anti-rabbit IgG.
Transfected HEK 293T cells on coverslips were washed twice
with PBS containing 4% sucrose at 24 hr after transfection and
then fixed with 4% paraformaldehyde and 4% sucrose in PBS
(room temperature, 20 min). Fixed cells were permeabilized with
PBS containing 0.2% Triton X-100 (4°C, 15 min). Coverslips were
blocked in 10% normal donkey serum in PBS at 4°C overnight, and
then visualized using anti-GluR2/3 (JH1707), anti-Myc (9E10), and
anti-GM130 (Pharmingen) antibodies.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
two figures with legends, and a conflict-of-interest statement and
are available with this article online at http://www.neuron.org/cgi/
content/full/cgi/47/5/709/DC1.
Acknowledgments
We are grateful to Mrs. C. Doherty and Mrs. M. Coulter, for antibody
preparation, and to Dr. G. Thomas and Dr. T. Tsunenari, for valuable
discussion and critical reading of the manuscript. GODZ cDNA is a
special gift from Dr. M. Mishina. This work was supported by re-
search grants from the HHMI and NIH. The authors have declared
a conflict of interest. For details, see the Supplemental Data.
Received: April 8, 2005
Revised: June 16, 2005
Accepted: June 28, 2005
Published: August 31, 2005
References
Alaluf, S., Mulvihill, E.R., and McIlhinney, R.A. (1995). The metabo-
tropic glutamate receptor mGluR4, but not mGluR1 alpha, is palmi-
toylated when expressed in BHK cells. J. Neurochem. 64, 1548–
1555.
Anderson, R.A., and Lovrien, R.E. (1984). Glycophorin is linked by
band 4.1 protein to the human erythrocyte membrane skeleton. Na-
ture 307, 655–658.
Beattie, E.C., Carroll, R.C., Yu, X., Morishita, W., Yasuda, H., von
Zastrow, M., and Malenka, R.C. (2000). Regulation of AMPA recep-
tor endocytosis by a signaling mechanism shared with LTD. Nat.
Neurosci. 3, 1291–1300.
Neuron
722Bijlmakers, M.J., and Marsh, M. (2003). The on-off story of protein
palmitoylation. Trends Cell Biol. 13, 32–42.
Bizzozero, O.A. (1995). Chemical analysis of acylation sites and
species. Methods Enzymol. 250, 361–379.
Bredt, D.S., and Nicoll, R.A. (2003). AMPA receptor trafficking at
excitatory synapses. Neuron 40, 361–379.
Carroll, R.C., Beattie, E.C., Xia, H., Luscher, C., Altschuler, Y., Nicoll,
R.A., Malenka, R.C., and von Zastrow, M. (1999). Dynamin-depen-
dent endocytosis of ionotropic glutamate receptors. Proc. Natl.
Acad. Sci. USA 96, 14112–14117.
Carroll, R.C., Beattie, E.C., von Zastrow, M., and Malenka, R.C.
(2001). Role of AMPA receptor endocytosis in synaptic plasticity.
Nat. Rev. Neurosci. 2, 315–324.
Chien, A.J., Carr, K.M., Shirokov, R.E., Rios, E., and Hosey, M.M.
(1996). Identification of palmitoylation sites within the L-type cal-
cium channel beta2a subunit and effects on channel function. J.
Biol. Chem. 271, 26465–26468.
Coleman, S.K., Cai, C., Mottershead, D.G., Haapalahti, J.P., and
Keinanen, K. (2003). Surface expression of GluR-D AMPA receptor
is dependent on an interaction between its C-terminal domain and
a 4.1 protein. J. Neurosci. 23, 798–806.
Craven, S.E., El-Husseini, A.E., and Bredt, D.S. (1999). Synaptic tar-
geting of the postsynaptic density protein PSD-95 mediated by
lipid and protein motifs. Neuron 22, 497–509.
DeSouza, S., Fu, J., States, B.A., and Ziff, E.B. (2002). Differential
palmitoylation directs the AMPA receptor-binding protein ABP to
spines or to intracellular clusters. J. Neurosci. 22, 3493–3503.
Dietrich, L.E., and Ungermann, C. (2004). On the mechanism of pro-
tein palmitoylation. EMBO Rep. 5, 1053–1057.
Dietrich, L.E., Gurezka, R., Veit, M., and Ungermann, C. (2004). The
SNARE Ykt6 mediates protein palmitoylation during an early stage
of homotypic vacuole fusion. EMBO J. 23, 45–53.
Drisdel, R.C., Manzana, E., and Green, W.N. (2004). The role of pal-
mitoylation in functional expression of nicotinic alpha7 receptors.
J. Neurosci. 24, 10502–10510.
El-Husseini, A.E., and Bredt, D.S. (2002). Protein palmitoylation: a
regulator of neuronal development and function. Nat. Rev. Neu-
rosci. 3, 791–802.
El-Husseini, A.E., Craven, S.E., Chetkovich, D.M., Firestein, B.L.,
Schnell, E., Aoki, C., and Bredt, D.S. (2000a). Dual palmitoylation of
PSD-95 mediates its vesiculotubular sorting, postsynaptic tar-
geting, and ion channel clustering. J. Cell Biol. 148, 159–172.
El-Husseini, A.E., Topinka, J.R., Lehrer-Graiwer, J.E., Firestein, B.L.,
Craven, S.E., Aoki, C., and Bredt, D.S. (2000b). Ion channel cluster-
ing by membrane-associated guanylate kinases. Differential regu-
lation by N-terminal lipid and metal binding motifs. J. Biol. Chem.
275, 23904–23910.
El-Husseini, A.E, Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q.,
Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll,
R.A., and Bredt, D.S. (2002). Synaptic strength regulated by palmi-
tate cycling on PSD-95. Cell 108, 849–863.
Fukata, M., Fukata, Y., Adesnik, H., Nicoll, R.A., and Bredt, D.S.
(2004). Identification of PSD-95 palmitoylating enzymes. Neuron 44,
987–996.
Gauthier-Campbell, C., Bredt, D.S., Murphy, T.H., and El-Husseini
Ael, D. (2004). Regulation of dendritic branching and filopodia for-
mation in hippocampal neurons by specific acylated protein motifs.
Mol. Biol. Cell 15, 2205–2217.
Greger, I.H., Khatri, L., Kong, X., and Ziff, E.B. (2003). AMPA recep-
tor tetramerization is mediated by Q/R editing. Neuron 40, 763–774.
Hayashi, T., and Huganir, R.L. (2004). Tyrosine phosphorylation and
regulation of the AMPA receptor by SRC family tyrosine kinases. J.
Neurosci. 24, 6152–6160.
Hollmann, M., and Heinemann, S. (1994). Cloned glutamate recep-
tors. Annu. Rev. Neurosci. 17, 31–108.
Huang, K., Yanai, A., Kang, R., Arstikaitis, P., Singaraja, R.R.,
Metzler, M., Mullard, A., Haigh, B., Gauthier-Campbell, C., Gute-
kunst, C.A., et al. (2004). Huntingtin-interacting protein HIP14 is a
p
m
K
S
o
N
L
M
n
n
L
I
c
N
n
p
c
N
M
p
c
N
G
h
1
P
(
b
C
P
(
A
P
R
i
c
P
U
a
l
t
Q
B
C
A
R
m
B
R
D
a
S
a
o
C
S
t
1
7
S
p
S
d
S
R
t
T
Nalmitoyl transferase involved in palmitoylation and trafficking of
ultiple neuronal proteins. Neuron 44, 977–986.
eller, C.A., Yuan, X., Panzanelli, P., Martin, M.L., Alldred, M.,
assoe-Pognetto, M., and Luscher, B. (2004). The gamma2 subunit
f GABA(A) receptors is a substrate for palmitoylation by GODZ. J.
eurosci. 24, 5881–5891.
in, J.W., Ju, W., Foster, K., Lee, S.H., Ahmadian, G., Wyszynski,
., Wang, Y.T., and Sheng, M. (2000). Distinct molecular mecha-
isms and divergent endocytotic pathways of AMPA receptor inter-
alization. Nat. Neurosci. 3, 1282–1290.
obo, S., Greentree, W.K., Linder, M.E., and Deschenes, R.J. (2002).
dentification of a Ras palmitoyltransferase in Saccharomyces
erevisiae. J. Biol. Chem. 277, 41268–41273.
g, G.Y., George, S.R., Zastawny, R.L., Caron, M., Bouvier, M., Den-
is, M., and O’Dowd, B.F. (1993). Human serotonin1B receptor ex-
ression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl
yclase inhibition. Biochemistry 32, 11727–11733.
g, G.Y., Mouillac, B., George, S.R., Caron, M., Dennis, M., Bouvier,
., and O’Dowd, B.F. (1994a). Desensitization, phosphorylation and
almitoylation of the human dopamine D1 receptor. Eur. J. Pharma-
ol. 267, 7–19.
g, G.Y., O’Dowd, B.F., Caron, M., Dennis, M., Brann, M.R., and
eorge, S.R. (1994b). Phosphorylation and palmitoylation of the
uman D2L dopamine receptor in Sf9 cells. J. Neurochem. 63,
589–1595.
asternack, G.R., Anderson, R.A., Leto, T.L., and Marchesi, V.T.
1985). Interactions between protein 4.1 and band 3. An alternative
inding site for an element of the membrane skeleton. J. Biol.
hem. 260, 3676–3683.
ickering, D.S., Taverna, F.A., Salter, M.W., and Hampson, D.R.
1995). Palmitoylation of the GluR6 kainate receptor. Proc. Natl.
cad. Sci. USA 92, 12090–12094.
onimaskin, E.G., Schmidt, M.F., Heine, M., Bickmeyer, U., and
ichter, D.W. (2001). 5-Hydroxytryptamine 4(a) receptor expressed
n Sf9 cells is palmitoylated in an agonist-dependent manner. Bio-
hem. J. 353, 627–634.
onimaskin, E.G., Heine, M., Joubert, L., Sebben, M., Bickmeyer,
., Richter, D.W., and Dumuis, A. (2002). The 5-hydroxytrypt-
mine(4a) receptor is palmitoylated at two different sites, and acy-
ation is critically involved in regulation of receptor constitutive ac-
ivity. J. Biol. Chem. 277, 2534–2546.
in, N., Platano, D., Olcese, R., Costantin, J.L., Stefani, E., and
irnbaumer, L. (1998). Unique regulatory properties of the type 2a
a2+ channel beta subunit caused by palmitoylation. Proc. Natl.
cad. Sci. USA 95, 4690–4695.
esh, M.D. (1999). Fatty acylation of proteins: new insights into
embrane targeting of myristoylated and palmitoylated proteins.
iochim. Biophys. Acta 1451, 1–16.
oth, A.F., Feng, Y., Chen, L., and Davis, N.G. (2002). The yeast
HHC cysteine-rich domain protein Akr1p is a palmitoyl transfer-
se. J. Cell Biol. 159, 23–28.
chmidt, J.W., and Catterall, W.A. (1987). Palmitoylation, sulfation,
nd glycosylation of the alpha subunit of the sodium channel. Role
f post-translational modifications in channel assembly. J. Biol.
hem. 262, 13713–13723.
hen, L., Liang, F., Walensky, L.D., and Huganir, R.L. (2000). Regula-
ion of AMPA receptor GluR1 subunit surface expression by a 4.
N-linked actin cytoskeletal association. J. Neurosci. 20, 7932–
940.
oderling, T.R., and Derkach, V.A. (2000). Postsynaptic protein
hosphorylation and LTP. Trends Neurosci. 23, 75–80.
ong, I., and Huganir, R.L. (2002). Regulation of AMPA receptors
uring synaptic plasticity. Trends Neurosci. 25, 578–588.
wope, S.L., Moss, S.J., Raymond, L.A., and Huganir, R.L. (1999).
egulation of ligand-gated ion channels by protein phosphoryla-
ion. Adv. Second Messenger Phosphoprotein Res. 33, 49–78.
omita, S., Chen, L., Kawasaki, Y., Petralia, R.S., Wenthold, R.J.,
icoll, R.A., and Bredt, D.S. (2003). Functional studies and distribu-
Palmitoylation of AMPA Receptor Subunits
723tion define a family of transmembrane AMPA receptor regulatory
proteins. J. Cell Biol. 161, 805–816.
Tomita, S., Fukata, M., Nicoll, R.A., and Bredt, D.S. (2004). Dynamic
interaction of stargazin-like TARPs with cycling AMPA receptors at
synapses. Science 303, 1508–1511.
Topinka, J.R., and Bredt, D.S. (1998). N-terminal palmitoylation of
PSD-95 regulates association with cell membranes and interaction
with K+ channel Kv1.4. Neuron 20, 125–134.
Tyler, J.M., Hargreaves, W.R., and Branton, D. (1979). Purification
of two spectrin-binding proteins: biochemical and electron micro-
scopic evidence for site-specific reassociation between spectrin
and bands 2.1 and 4.1. Proc. Natl. Acad. Sci. USA 76, 5192–5196.
Uemura, T., Mori, H., and Mishina, M. (2002). Isolation and charac-
terization of Golgi apparatus-specific GODZ with the DHHC zinc
finger domain. Biochem. Biophys. Res. Commun. 296, 492–496.
Vandenberghe, W., Nicoll, R.A., and Bredt, D.S. (2005). Stargazin is
an AMPA receptor auxiliary subunit. Proc. Natl. Acad. Sci. USA.
102, 485–490.
Verdoorn, T.A., Burnashev, N., Monyer, H., Seeburg, P.H., and Sak-
mann, B. (1991). Structural determinants of ion flow through recom-
binant glutamate receptor channels. Science 252, 1715–1718.
Walensky, L.D., Blackshaw, S., Liao, D., Watkins, C.C., Weier, H.U.,
Parra, M., Huganir, R.L., Conboy, J.G., Mohandas, N., and Snyder,
S.H. (1999). A novel neuron-enriched homolog of the erythrocyte
membrane cytoskeletal protein 4.1. J. Neurosci. 19, 6457–6467.
Yamazaki, M., Fukaya, M., Abe, M., Ikeno, K., Kakizaki, T., Wata-
nabe, M., and Sakimura, K. (2001). Differential palmitoylation of two
mouse glutamate receptor interacting protein 1 forms with different
N-terminal sequences. Neurosci. Lett. 304, 81–84.
